Home  >  Research  >  Labs  >  Centres & Facilities  >  Proteomics

OVERVIEW

Proteomics International is an ASX-listed (stock code PIQ) medical technology company and a global leader in predictive diagnostics and specialist analytical services. Proteomics International provides advanced mass spectrometry services to support biomedical research, drug development, and clinical innovation.

Proteomics International also co-manages the WA Proteomics Facility with The University of Western Australia (UWA) under the Bioplatforms Australia network—providing world-class proteomics infrastructure for academic and industry research.

On this page, you’ll find the following information:

Analytical Services

Proteomics International offers a comprehensive range of analytical and proteomics services through its ISO 17025-accredited laboratory.

Services include:

Pharmacokinetic Testing

  • Pre-clinical and clinical pharmacokinetic (PK) analysis via LC-MS/MS for small molecules & peptide drugs.
  • Method development and validation meeting international bioanalytical guidelines.
  • Handling of diverse biological matrices (serum, plasma, tissue, urine).
  • Automated high-throughput sample processing.
  • Full PK reporting using industry-standard software.

Biomarker Discovery & Validation

  • Discovery of diagnostic and disease-associated biomarkers using the Promarker® platform.
  • TMT-based quantitative proteomics for candidate identification.
  • Targeted mass-spec validation using MRM/SRM.
  • Custom assay development for pharmacodynamic, diagnostic, or clinical applications.

Biosimilars & Biologics Drug Characterisation

  • Structural and physicochemical characterisation of biologic therapeutics.
  • Intact mass measurement, peptide mapping, N- and C-terminal analysis.
  • Disulfide bond analysis and detailed impurity profiling.
  • Glycosylation and other post-translational modification (PTM) studies.
  • Specialised offerings including:
    • 2-tag based Disulfide quantification
    • Isoaspartate quantification
    • Pyroglutamination quantification
    • C-terminal truncation analysis

Specialist Protein Testing

  • Protein Identification
  • Proteome Mapping & Quantitation
  • Post-Translational Modification (PTM) Analysis & many more…

Scientific Consultation & Project Support

  • Expert guidance for experimental design and analytical strategy.
  • Custom quotations and tailored project workflows.
  • Support for grant applications, collaborations, and industry projects.

Diagnostics (Promarker® Platform)

  •    Predicting diabetic kidney disease before symptoms develop.
  •   Oesophageal cancer detection
  • Pipeline test in Endometriosis, asthma, COPD, diabetic retinopathy and oxidative stress.

More details on the Proteomics website.

Latest News

You will find our latest news and media coverage here.

Get in Touch

Proteomics International
T: +61 8 9389 1992
Service enquiries: Submit your Service Enquiry
Other Enquiries: Contact Us
Social Media:

LinkedIn: @Proteomics International
X (Twitter): @ProteomicsI